Lipid and lipoprotein levels remain stable in acute ischemic stroke: The Northern Manhattan Stroke Study

Atherosclerosis

Volumn 139, Issue 2, 1998, Pages 391-399

  Kargman, D E ^a   Tuck, C ^a   Berglund, L ^a   Lin, I F ^a   Mukherjee, R S ^a   Thompson, E V ^a   Jones, J ^a   Boden Albala, B ^a   Paik, M C ^a   Sacco, R L ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Acute phase reactants; Lipids; Lipoprotein(a); Stroke

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; LIPOPROTEIN A;

ACUTE PHASE RESPONSE; ARTICLE; ATHEROSCLEROSIS; BRAIN INFARCTION; BRAIN ISCHEMIA; CORONARY ARTERY DISEASE; HUMAN; HUMAN CELL; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; REPRODUCIBILITY; STROKE;

ACUTE DISEASE; ACUTE-PHASE REACTION; AGED; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; CEREBROVASCULAR DISORDERS; FEMALE; HAPTOGLOBINS; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OROSOMUCOID; PILOT PROJECTS; SERUM ALBUMIN;

EID: 0031859239     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00085-9     Document Type: Article

References (43)

1. Summary of the National Cholesterol Education Program (NCEP) Adult Treatment Panel II Report. J Am Med Assoc 1993;269:3015-3023.
2. Smith G.D., Shipley M.J., Marmot M.G., Rose G. Plasma cholesterol concentration and mortality. J Am Med Assoc. 267:1992;70-76.
3. Rhoads G.G., Dahlen G., Berg K., Morton N.E., Dannenberg A.L. Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc. 256:1986;2540-2544.
4. Dahlen G.H., Guyton J.R., Attar M., Farmer J.A., Kautz J.A., Gotto A.M. Jr. Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation. 74:1986;758-765.
5. Sandholzer C., Saha N., Kark J.D., Rees A., Jaross W., Dieplinger H., Hoppichler F., Boerwinkle E., Uterman G. Apo(a) isoforms predict risk for coronary heart disease: a study in six populations. Arterioscler Thromb. 12:1992;1214-1226.
6. Rosengren A., Wilhelmsen L., Eriksson E., Risberg B., Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. Br Med J. 301:1990;1248-1251.
7. Schaefer E.J., Lamon-Fava S., Jenner J.L., McNamara J.R., Ordovas J.M., Davis C.E., Abolafia J.M., Lippel K., Levy R.I. Lipoprotein(a) levels and risk of coronary heart disease in men: the lipid research clinics coronary primary prevention trial. J Am Med Assoc. 271:1994;999-1003.
8. Bostom A.G., Cupples A.G., Cupples L.A., Jenner J.L., Ordovas J.M., Seman L.J., Wilson P.W.F., Schaefer E.J., Castelli W.P. Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger: a prospective study. J Am Med Assoc. 276:1996;544-548.
9. Orth-Gomer K., Mittleman M.A., Schenck-Gustafsson K., Wamala S.P., Eriksson M., Belkic K., Kirkeeide R., Svane B., Ryden L. Lipoprotein(a) as determinant of coronary heart disease in young women. Circulation. 95:1997;329-334.
10. Schreiner P.J., Chambles L.E., Brown S.A., Watson R.L., Toole J., Heiss G. Lipoprotein(a) as a correlate of stroke and transient ischemic attack prevalence in a biracial cohort: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 4:1994;351-359.
11. Nagayama M., Shinohara Y., Nagayama T. Lipoprotein(a) and ischemic cerebrovascular disease in young adults. Stroke. 25:1994;74-78.
12. Van Kooten F., van Krimpen J., Dippel D.W., Hoogerbrugge N. Lipoprotein(a) in patients with cerebral ischemia. Stroke. 27:1996;123-125.
13. Konemari G. Lipoprotein(a) and other risk factors for cerebral infarction. Hiroshima J Med Sci. 44:1995;65-77.
14. Zhuang Y.Y., Wang J.J., Xu P. Increased lipoprotein(a) as an independent risk factor for cardiovascular and cerebrovascular diseases. Chin Med J. 106:1993;597-600.
15. Jurgens G., Taddei-Peters W.C., Koltringer P., Petek W., Chen Q., Greilberger J., Macomber P.F., Butman B.T., Stead A.G., Ransom J.H. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke. 26:1995;1841-1848.
16. Boerwinkle E., Leffert C.C., Lin J., Lackner C., Chiesa G., Hobbs H.H. Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest. 90:1992;52-60.
17. Uterman G. The mysteries of lipoprotein(a). Science. 246:1989;904-910.
18. Biorck G., Blomqvist G., Sievers J. Cholesterol values in patients with acute myocardial infarction and in a normal control group. Acta Med Scand. 156:1957;493-497.
19. Dodds C., Mills G.L. Influence of myocardial infarction on plasma-lipoprotein concentration. Lancet. 1:1959;160-163.
20. Watson W., Buchanon K.D., Dickon C. Serum cholesterol levels after myocardial infarction. Br J Med. 2:1963;709-712.
21. Fyfe T., Baxter R.H., Cochran K.M., Booth E.M. Plasma lipid changes after myocardial infarction. Lancet. 2:1971;997-1001.
22. Sewdarsen M., Vythilingum S., Jialal I., Nadar R. Plasma lipids can be reliably assessed within 24 hours after acute myocardial infarction. Postgrad Med J. 64:1988;352-356.
23. Ahnve S., Angelin B., Edhag O., Berglund L. Early determinations of serum lipids and apolipoproteins in acute myocardial infarction: possibility for immediate intervention. J Intern Med. 297:1989;226-231.
24. Mendez I., Hachinski V., Wolfe B. Serum lipids after stroke. Neurology. 37:1987;507-511.
25. Woo J., Lam C.W.K., Kay R., Wong H.Y., Teoh R., Nicholls M.G. Acute and long-term changes in serum lipids after acute stroke. Stroke. 21:1990;1407-1411.
26. Hollanders F.D., Shafar J. Serum lipid changes following the completed stroke syndrome. Postgrad Med J. 51:1975;386-389.
27. Aull S., Lalouschek W., Schnider P., Sinzinger H., Uhl F., Zeiler K. Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. Am J Med. 101:1996;291-298.
28. Blauw G.J., Lagaay A.M., Smelt A.H.M., Westendorp R.G.J. Stroke, statins, and cholesterol: A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke. 28:1997;946-950.
29. Crouse I.I.I. Jr., Byington R.P., Hoen H.M., Furburg C.D. Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med. 157:1997;1305-1310.
30. Tuck CH, Holleran S, Berglund L. Hormonal regulation of lipoprotein(a): Effects of estrogen replacement therapy on lipoprotein(a) and acute phase reactants in post-menopausal women. Arterioscler Thromb Vasc Biol 1997 (in press).
31. Gilllery P., Arthus P., Cuperlier C., Circaud R. Rate nephelometric assay of serum lipoprotein(a). Clin Chem. 39:1993;503-508.
32. Lopes-Virella M.F., Stone P., Ellis S., Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 23:1977;882-884.
33. Friedwald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
34. Laird N.M., Ware J.H. Random-effects models for longitudinal data. Biometrics. 38:1982;963-974.
35. Carlsson R., Lindberg G., Westin L., Israelson B. Serum lipids four weeks after acute myocardial infarction are a valid basis for lipid lowering intervention in patients receiving thrombolysis. Br Heart J. 74:1995;18-20.
36. Ryder R.E.J., Hayes T.M., Mulligan J.P., Kingswood J.C., Williams S., Owens D.R. How soon after myocardial infarction should plasma lipid values be assessed? Br Med J. 289:1984;1651-1653.
37. Gore J.M., Goldberg R.J., Matsumoto A.S., Castelli W.P., McNamara P.M., Dalen J.E. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol. 54:1984;722-725.
38. Heldenberg D., Rubenstein A., Levtov O., Berns L., Werbin B., Tamir I. Serum lipids and lipoprotein concentrations during the acute phase of myocardial infarction. Atherosclerosis. 35:1980;433-437.
39. Maeda S., Abe A., Seishima M., Makino K., Noma A., Kawade M. Transient changes of serum lipoprotein(a) as an acute phase protein. Atherosclerosis. 78:1989;145-150.
40. Noma A., Abe A., Maeda S., Seishima M., Makino K., Yano Y., Shimokawa K. Lp(a): an acute-phase reactant? Chem Phys Lipids. 67/68:1994;411-417.
41. Axelsson K., Asplund K., Norberg A., Eriksson S. Eating problems and nutritional status during hospital stay of patients with severe stroke. J Am Diet Assoc. 89:1989;1092-1096.
42. Smithard D.G., O'Neill P.A., Park C., Morris J., Wyatt R., England R., Martin D.F. Complications and outcome after acute stroke. Does dysphagic matter? Stroke. 27:1996;1200-1204.
43. Hennekens CH, Buring JE. Epidemiology in Medicine. Boston: Little Brown, 1987:34-35.